CA
GDRX icon

Cornerstone Advisory’s GoodRx Holdings GDRX Stock Holding History

Cornerstone Advisory’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-148
Closed -$5K – 415
2021
Q4 		$5K Buy
+148
New +$5.95K ﹤0.01% 667

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
TCMX
Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
RRCP
Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

Cornerstone Advisory's GDRX Position: Q1 2022 in Review

Cornerstone Advisory sold out of GoodRx Holdings (GDRX) in Q1 2022, closing a stake of 148 shares — an estimated $5K sold.

Cornerstone Advisory first reported a position in GDRX in Q4 2021 and held it in 1 quarter. The position peaked at $5K in Q4 2021. 167 funds tracked by Wall St. Rank hold GDRX as of Q1 2022.

  • Cornerstone Advisory reported no remaining GoodRx Holdings position as of Q1 2022 after selling out during the quarter.
  • Cornerstone Advisory sold 148 GoodRx Holdings shares in Q1 2022, an estimated $5K.
  • Cornerstone Advisory first reported a position in GoodRx Holdings in Q4 2021 and held it in 1 quarter.
  • Cornerstone Advisory's GoodRx Holdings position peaked at $5K in Q4 2021.
  • 167 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2022.

Based on Cornerstone Advisory's 13F filing for Q1 2022, filed 20 May 2022.